Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Proceedings of the National Academy of Sciences

Topics

Biology

Immunology

Hematology

Rheumatology

Ecology, Evolution, Behavior And Systematics

Show all topics

DOI

10.1073/pnas.0606176103

Other Formats

PDF